PharmaTimes - May 2018

For months now we’ve been hearing all about how artificial intelligence can change pharma and healthcare, from expediting R&D to diagnosing patients at home, and so for this month’s issue we thought that we’d take an in-depth look at what has to be the most exciting technological trend in the industry right now (p20).

But it’s important to remember the patient in amongst all this talk of machines. On p30 we ask whether pharma is truly walking the patient centric walk despite years of talking the talk, and if not, what it can do to get there. On that subject, we have exclusive comment from Dr Oleksandr Gorbenko, director, global patient affairs of ViiV (p45) reflecting on the company’s second year in a row at the top of the PatientView corporate reputation survey and how pharma can instil trust in an industry that has historically been out of favour with the public.

It’s an important year for the PharmaTimes competitions, as later this year we’ll be celebrating Marketer of the Year’s 25th anniversary. To mark this momentous milestone we catch up with some past winners and take a look at how pharma marketing has changed on p36. MOY and its sister competition Communications Team of the Year are both now open for entry, so don’t miss your chance to enter at pharmatimes.com/competitions. And don’t forget that tickets are on now sale for 2018’s International Clinical Researcher of the Year competition!

May 2018 - magazine highlights

Women in pharma: Eugenia Wachters and Jasmin Hussein

Eugenia Wachters and Jasmin Hussein from Sanofi talk about...

AI meets IP

New machine learning technologies may have far-reaching, u...

Trusting pharma

ViiV Healthcare has once again topped the annual PatientVi...

SmartPeople: Bill Byrom

With over 25 years experience in clinical development and...

Changing 
careers for 
25 years

Celebrating 25 years of the Marketer of the Year competiti...

Walking the patient 
centric talk

Can pharma prove that being patient centric is more than j...

Nanomedicine: the next breakthrough in oncology?

A look at the exciting breakthroughs in using microscopic...

A new era of data protection

The implications of GDPR on pharma and its relationship wi...

Pharma and data: Knowledge is power

Sanofi’s Milind Kamkolkar is the first enterprise chief da...

Company focus: Exscientia

With several high-profile collaborations under its belt, E...

What’s up, AI doc?

When it comes to diagnosis, AI offers hard-pressed clinici...

AI: the foundation for life sciences 2.0?

How machine learning technology could significantly change...